M. Rico

514 total citations
26 papers, 229 citations indexed

About

M. Rico is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M. Rico has authored 26 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M. Rico's work include Lung Cancer Diagnosis and Treatment (8 papers), Cancer survivorship and care (6 papers) and Lung Cancer Treatments and Mutations (6 papers). M. Rico is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Cancer survivorship and care (6 papers) and Lung Cancer Treatments and Mutations (6 papers). M. Rico collaborates with scholars based in Spain, Austria and Italy. M. Rico's co-authors include Juan Ignacio Arrarás, Gemma Asín, Fernando Arias de la Vega, Ruth Vera, Maite Martínez, Javier Suárez, Berta Hernández, Virginia Arrazubi, Lucía Teijeira and Enrique Martı́nez and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Radiation Oncology*Biology*Physics and Quality of Life Research.

In The Last Decade

M. Rico

23 papers receiving 227 citations

Peers

M. Rico
Comparison fields: 5 of 50
  • Oncology 145
  • Pulmonary and Respiratory Medicine 79
  • Surgery 45
  • General Health Professions 43
  • Public Health, Environmental and Occupational Health 35
Replace Gemma Asín with:
Gemma Asín Spain
Yi-Ting Hwang Taiwan
Nina Cavalli‐Björkman Sweden
Ian M. Allen United States
Chantal M den Bakker Netherlands
Eugenie Younger United Kingdom
Mary Uhlenhopp United States
Mogens Grønvold Denmark
Victoria Gamerman United States
Kimberly A. Herget United States
Gemma Asín Spain View profile →
Citations per field, relative to M. Rico
M. Rico · 1×
Citations per year, relative to M. Rico
M. Rico · 1×

Countries citing papers authored by M. Rico

Since Specialization
Citations

This map shows the geographic impact of M. Rico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rico more than expected).

Fields of papers citing papers by M. Rico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Rico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rico. The network helps show where M. Rico may publish in the future.

Co-authorship network of co-authors of M. Rico

This figure shows the co-authorship network connecting the top 25 collaborators of M. Rico. A scholar is included among the top collaborators of M. Rico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Rico. M. Rico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Hypofractionation and SBRT in inoperable locally advanced non-small cell lung cancer
2021 ·Journal of Clinical and Translational Research ·M. Rico, (unknown), (unknown), (unknown), (unknown), Enrique Martı́nez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)
2
2
Phase II Trial of SBRT and Androgen Deprivation for Oligometastases in Prostate Cancer
2021 ·International Journal of Radiation Oncology*Biology*Physics ·Antonio J. Conde-Moreno, Fernando Durán López, A. Hervás, V. Morillo, (unknown), (unknown), (unknown), (unknown), M. Rico, M. L. Vázquez de la Torre, Pilar Samper, Luís A. Pérez-Romasanta, (unknown), Carolina Ibáñez, F. Ferrer, A. Zapatero, (unknown), Aurora Rodríguez, C. Ferrer Albiach
7
3
General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition
2021 ·Health and Quality of Life Outcomes ·Juan Ignacio Arrarás, Sandra Nolte, Gregor Liegl, Matthias Rose, (unknown), José Juan Illarramendi, (unknown), M. Rico, (unknown), Gemma Asín, (unknown), (unknown), Ruth Vera, Fabio Efficace, Johannes M. Giesinger, (unknown)
14
4
GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours
2021 ·World Journal of Clinical Oncology ·M. Rico, (unknown), (unknown), (unknown), (unknown), (unknown), Javier Serrano, (unknown), (unknown), (unknown), (unknown), Felipe Couñago
3
5
Hypofractionation and Stereotactic Body Radiation Therapy in Inoperable Locally Advanced Non-small Cell Lung Cancer.
2021 ·PubMed ·M. Rico, (unknown), (unknown), (unknown), (unknown), Enrique Martı́nez
2
6
How to integrate stereotactic body radiation therapy and hypofractionation in the management of stage III lung cancer in the age of immunotherapy
2020 ·SHILAP Revista de lepidopterología ·M. Rico, (unknown), Alfonso Martı́n, (unknown), (unknown), Eliana C. Martinez
3
7
Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group
2018 ·Clinical Lung Cancer ·Núria Rodríguez, Felipe Couñago, José López, Patricia Calvo, M. Murcia, M. Rico, Carmen Vallejo, J. Luna, (unknown), (unknown), Núria Farré, R.M. Manero, Xavier Durán, Pilar Samper
12
8
Recent developments in radiotherapy for small-cell lung cancer: a review by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
2017 ·Clinical & Translational Oncology ·Núria Rodríguez, Patricia Calvo, M. Rico, M. Martín, Felipe Couñago, (unknown), (unknown), Aurora Rodríguez
6
9
Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy
2016 ·Clinical & Translational Oncology ·M. Rico, Eliana C. Martinez, (unknown), Begoña Bermejo, Paola Navarrete, (unknown), (unknown), (unknown), E. Villafranca, Javier Aristu
1
10
Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial
2016 ·OncoTargets and Therapy ·Enrique Martı́nez, M. Rico, Maite Martínez, Berta Hernández, (unknown), Manuel Dómine, Francesc Casas, Núria Viñolas, (unknown)
13
11
Quality of Life in Spanish advanced non-small-cell lung cancer patients: determinants of global QL and survival analyses
2016 ·SpringerPlus ·Juan Ignacio Arrarás, Berta Hernández, Maite Martínez, Koldo Cambra, M. Rico, José Juan Illarramendi, A. Viúdez, Berta Ibáñez, (unknown), Enrique Martı́nez, Ruth Vera
11
12
The EORTC QLQ-C15-PAL questionnaire: validation study for Spanish bone metastases patients
2013 ·Quality of Life Research ·Juan Ignacio Arrarás, Fernando Arias de la Vega, Gemma Asín, M. Rico, (unknown), (unknown), Koldo Cambra, (unknown), (unknown), (unknown), (unknown), M.A. Domínguez
23
13
Active breathing control in left breast irradiation, our experience center
2013 ·Reports of Practical Oncology & Radiotherapy ·(unknown), (unknown), (unknown), (unknown), (unknown), Gemma Asín, M. Rico, M.Á. Domínguez, F. Árias, (unknown), Eliana C. Martinez, E. Villafranca
1
14
Quality of life assessment by applying EORTC questionnaires to rectal cancer patients after surgery and neoadjuvant and adjuvant treatment
2013 ·Revista Española de Enfermedades Digestivas ·Juan Ignacio Arrarás, Javier Suárez, (unknown), Ruth Vera, Berta Ibáñez, Gemma Asín, A. Viúdez, (unknown), M. Rico, (unknown)
15
15
EP-1214 CHEST RADIOTHERAPY AFTER CHEMOTHERAPY AND PCI FOR SMALL CELL LUNG CANCER EXTENSIVE DISEASE
2012 ·Radiotherapy and Oncology ·M. Rico, (unknown), (unknown), (unknown), Benôıt Marin, Maite Martínez Aguillo, (unknown), (unknown), M. Luisa Albina, M.A. Domínguez
0
16
The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients
2011 ·Clinical & Translational Oncology ·Juan Ignacio Arrarás, Javier Suárez, Fernando Arias de la Vega, Ruth Vera, Gemma Asín, Virginia Arrazubi, M. Rico, Lucía Teijeira, (unknown)
52
17
The EORTC cancer in-patient satisfaction with care questionnaire: EORTC IN-PATSAT32
2009 ·Clinical & Translational Oncology ·Juan Ignacio Arrarás, Ruth Vera, Maite Martínez, Berta Hernández, Núria Laínez, M. Rico, (unknown), (unknown), Gemma Asín
20
18
The EORTC cancer outpatient satisfaction with care questionnaire in ambulatory radiotherapy: EORTC OUT‐PATSAT35 RT. Validation study for Spanish patients
2009 ·Psycho-Oncology ·Juan Ignacio Arrarás, M. Rico, (unknown), (unknown), Gemma Asín, Maite Martínez, Berta Hernández, Fernando Arias, Enrique Martı́nez
20
19
The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients
2009 ·Clinical & Translational Oncology ·Juan Ignacio Arrarás, E. Villafranca, Fernando Arias de la Vega, (unknown), M. Rico, (unknown), Gemma Asín, (unknown), M.A. Domínguez, Núria Laínez, (unknown), Enrique Martı́nez, Maite Martínez
15
20
Braquiterapia guiada por imagen
2009 ·Anales del Sistema Sanitario de Navarra ·E. Villafranca, (unknown), (unknown), Gemma Asín, M. Rico, (unknown)
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gemma Asín Breakdown of academic impact, for papers by Yi-Ting Hwang Breakdown of academic impact, for papers by Nina Cavalli‐Björkman Breakdown of academic impact, for papers by Ian M. Allen Breakdown of academic impact, for papers by Chantal M den Bakker Breakdown of academic impact, for papers by Eugenie Younger Breakdown of academic impact, for papers by Mary Uhlenhopp Breakdown of academic impact, for papers by Mogens Grønvold Breakdown of academic impact, for papers by Victoria Gamerman Breakdown of academic impact, for papers by Kimberly A. Herget
Rankless by CCL
2026